Emergent Biosolutions (EBS) Issues Q3 Miss
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.23 +6.13%
EPS Growth %: -138.7%
Financial Fact:
Cost of product sales: 39.56M
Today's EPS Names:
ANAB, ANIX, MNY, More
EPS Growth %: -138.7%
Financial Fact:
Cost of product sales: 39.56M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Emergent Biosolutions (NYSE: EBS) reported Q3 EPS of $0.04, $0.06 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $58.8 million versus the consensus estimate of $63.59 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
- IBEX Limited (IBEX) Tops Q4 EPS by 6c; offers guidance
- Korn Ferry (KFY) Tops Q1 EPS by 7c, Beats on Revenue; Offers Q2 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
